Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innocutis Holdings LLC

Division of Cipher Pharmaceuticals Inc.
www.innocutis.com

Latest From Innocutis Holdings LLC

Deals In Depth: April 2015

Bristol is trying to build off of Eliquis momentum, signing a cardiovascular gene therapy deal with uniQure; Celgene capitalized on build-to-buy model and exercised option for Quanticel. Biopharma financing was down by almost $3 billion, while device fundraising was slightly up.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, May 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Research/Analytical, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April 2015.

BioPharmaceutical Medical Device

Onxeo Plans Clinical Trials For Three Phase III Orphan Oncologics

The year-old pan-European biotech is targeting advanced liver cancer, severe mucositis and the rare cancer, peripheral T-cell lymphoma, for its first products in the orphan oncology niche.

BioPharmaceutical France

Deals Shaping The Medical Industry, May 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced March through April 2014

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cipher Pharmaceuticals Inc.
  • Senior Management
  • Joseph Pecora, CEO
    Mark Spina, SVP, Fin. & Treasury
    Mark Reed, Dir., Sales.
    Daniel Ward, Med. Dir.
  • Contact Info
  • Innocutis Holdings LLC
    Phone: (843) 965-8333
    171 Church St.
    Ste. 140
    Charleston, SC 29401
    USA
UsernamePublicRestriction

Register